Influence of some environmental variables and addition of r-lysozyme on efficacy of Vibrio harveyi phage for therapy
- 7 Downloads
Bacteriophage therapy is a viable proposition for controlling luminous vibriosis caused by Vibrio harveyi in shrimp aquaculture. However, environmental factors influence the growth and activity of phage and affect its efficiency in controlling bacterial diseases. An essential problem in the use of vibrio phage as a therapeutic agent was the development of resistance to phage attachment, rendering them resistant to the lytic action of phage. This problem could be overcome by applying a cocktail of phages. This study aimed to evaluate the effect of salinity and pH on the phage activity and also to study the role of recombinant shrimp lysozyme on the performance of the V. harveyi phage. Out of three different levels of salinity (20, 25 and 30 ppt) and pH (6, 7 and 8) tested, optimum phage activity was observed at a salinity of 25 ppt and at neutral pH. Application of recombinant shrimp lysozyme in combination with V. harveyi phage significantly improved the activity of phage in in vitro assay as well as in microcosm study using seawater. The application of phage along with lysozyme can be a useful approach to overcome the inability of phage to enter the bacteria and thus eliminate or reduce fish/shrimp pathogenic bacteria in aquaculture.
KeywordsLysozyme pH Phage therapy Salinity Vibrio harveyi
The funding support received from the Department of Biotechnology, Govt. of India through the project on ‘Programme Support to Aquaculture and Biotechnology’ awarded to Indrani Karunasagar, Principal Investigator, is gratefully acknowledged.
- Baticados MCL and Paclibare JO 1992. The use of chemotherapeutic agents in aquaculture in the Philippines; in Diseases in Asian Aquaculture I Shariff M, Subasinghe RP and Arthur JR (Eds.) (Asian Fisheries Society, Manila) pp 531–546Google Scholar
- Choudhury TG, Maiti B, Venugopal MN and Karunasagar I 2012 Effect of total dissolved solids (TDS) and temperature on bacteriophage therapy against luminous vibriosis in shrimp. Isr. J. Aquacult. Bamid 64 761Google Scholar
- de-la-Re-Vega E, Garcia-Galaz A, Diaz-Cinco ME and Sotelo-Mundo RR 2006 White shrimp (Litopenaeus Vannamei) recombinant lysozyme has antibacterial activity against Gram negative bacteria: Vibrio alginolyticus, VibrioparahaemolyticusandVibrio cholerae. Fish Shellfish Immunol. 20 405–408CrossRefGoogle Scholar
- Golkar Z, Bagasra O and Pace DG 2014 Bacteriophage therapy: a potential solution for the antibiotic resistance crisis. J. Infect. Dev. Countries 8 129–136Google Scholar
- Luo ZH, Yu YP, Jost G, Liu WH, Huang XL and Gu L 2015 Characterization of two bacteriophages for specific treatment of biofilm formed by a Vibrio sp. isolated from an abalone farm. Aquacult. Res. 47 1–9Google Scholar
- Madigan MT, Martinko JM and Parker J 1997 Brock biology of microorganisms eight edition (Prentice Hall International, Inc.)Google Scholar
- Pelczar Jr. MJ, Chan ECS and Kreig NR 1996 Microbiology (Tata McGraw Hill Edition, New York), pp 415–434Google Scholar
- Phumkhachorn P and Rattanachaikunsopon P 2010 Isolation and partial characterization of a bacteriophage infecting the shrimp pathogen Vibrio harveyi. Afr. J. Microbiol. Res. 4 1794–1800Google Scholar
- Silva LVA 2005 Control of Vibrio vulnificus and Vibrio parahaemolyticus in oysters. Dissertation. Department of Food Science, Louisiana State University.Google Scholar
- Sunaryanto A and Mariam A 1986 Occurrence of a pathogenic bacteria causing luminescence in penaeid larvae in Indonesian hatcheries. Bull. Brackishwat. Aquacult. Dev. Cent. 8 105–112Google Scholar